were detected, after in vitro culture with MW antigen and recombinant human interleukin-2, in the efferent lymph and peripheral blood of sheep chronically infected with MVV. Cytotoxicity was mediated by CD8 ÷ lymphocytes and was specific for particular strains of MVV. These precursor CTL were detected in the blood between day 23 and day 100 after infection via the skin. In one out of seven persistently infected sheep MVV-specific cytotoxicity was seen in uncultured peripheral blood cells. Again the effector population consisted of CD8 ÷ lymphocytes. The only other viral infections in which CTL have been detected in peripheral blood mononuclear cells prior to secondary stimulation are those caused by the simian and human immunodeficiency viruses.
Introduction
Cytotoxic T lymphocytes (CTL) are important in mediating the clearance of virus from infected hosts during acute infections (e.g. influenza; McMichael et al., 1983) . In persistent infections although the virus is not cleared completely there is a role for CTL in maintaining reduced viral loads within the host (e.g. cytomegalovirus; Borysiewicz et al., 1983) . In human immunodeficiency virus (HIV) infection especially, CTL have been implicated in maintaining the low levels of virus seen during the asymptomatic period (reviewed by Nixon, 1992) . When the CTL precursor frequency falls, the amount of viral antigen and infectious virus detectable increases with the concomitant progression of the infected individual into patent AIDS. Several mechanisms have been put forward to explain why the CTL precursor frequency may decrease in the later stages of HIV disease: exhaustion of the precursor pool by repeated antigenic stimulation, virus escape mutants or lack of T cell help due to the depletion in CD4 ÷ cells. There are several animal lentiviral models showing the presence of CTL [simian immunodeficiency virus (SIV) : Yamamoto et aL, 1990; Miller et al., 1990; Vowels et al., 1989 ; feline immunodeficiency virus (FIV) : Song et aL, 1992] but these also involve infection of CD4+ cells and immunodeficiency of the host in later stages of the disease.
We have investigated sheep infected with the prototypic lentivirus maedi-visna virus (MVV) for the presence of CTL. Although MVV causes a lentiviral infection, the virus does not infect CD4 + lymphocytes and is restricted in tropism to cells of the monocyte/ macrophage lineage (Narayan et al., 1982; Gendelman et al., 1985) and possibly other antigen-presenting cell lineages (Gorrell et al., 1992) . Since there is no gross immune deficiency syndrome this model provides a useful tool for analysing the development of immunological reactivity to a lentivirus in a situation where there is no destruction of CD4 + lymphocytes. In this paper we have studied the development of CTL activity in the circulating lymphocytes of persistently infected sheep and characterized the cell type responsible for cytotoxicity.
Methods
Animals. Adult Finnish landrace and Finnish-crossed sheep were purchased from the Moredun Research Institute, Edinburgh, U.K. Sheep had been infected subcutaneously with MVV strain EV1 (Sargan et al., 1991) for 2 to 4 years (persistently infected) or for the time stated.
Prefemoral efferent lymphatic cannulation was performed as previously described on persistently infected sheep. Lymph was collected into sterile plastic bottles containing 909 U each of benzylpenicillin and streptomycin and 250 U of sodium heparin (Sigma).
Skin cell lines and virus culture. Autologous skin cell lines for each sheep were derived from skin biopsies taken as previously described before the sheep were infected . Cells were grown in Dulbecco's modified Eagle's medium supplemented with 2mM-Lglutamine, 100 U/ml benzylpenicillin, 100 U/ml streptomycin (DMEM) and 8 % fetal calf serum (FCS).
Skin cell monolayers were infected at 90% confluence with < 0"1 TCIDs0/cell of MVV strain EV1 (Sargan et al., 1991) in DMEM with 2% FCS. MVV strain 1514 (a gift from J. Clements, Department of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, Md., U.S.A.) was passaged as above in sheep choroid plexus cells. When extensive c.p.e, was seen [usually 4 to 7 days post-infection (p.i.)], the virus-containing cell supernatant was harvested, clarified by centrifugation (800 g for 20 rain) and stored at --70 °C. Each virus stock was titrated on skin cell monolayers and the concentration calculated using the quantal method of Reed and Muench . Virus was further titrated for the infection of target cells by expression of gag [immunofluorescent staining of acetone-fixed cells with monoclonal antibody (MAb) 415; Houwers, 1988] and by the recognition of targets in CTL assays with known stocks of virus as controls.
Vaccinia virus recombinant VgD52 (Cremer et al., 1985) , expressing herpes simplex virus type I strain KOS gtycoprotein D from the Ps8 late promoter in the thymidine kinase locus, was grown and titrated in BHK-21 cells as described previously (Blacklaws et al., 1990) .
Lymphocyte culture. Efferent lymph cells were washed once in RPMI 1640 medium supplemented with 2 mM-L-glutamine, 5 x 10 -5 M-2-mercaptoethanol, 100 U/ml benzylpenicillin, 100 U/ml streptomycin and 2% FCS (RPMI/2% FCS) before culture. Peripheral blood mononuclear cells (PBMC) were isolated from heparinized venous blood by taking buffy coat cells (the blood was centrifuged at 800 g for 15 min and the plasma/cell interface cells taken) which were then centrifuged over Lymphoprep (Nycomed) at 800 g for 15 min and the cells at the interface were washed twice with RPMI/2 % FCS before culture. Lymphocyte cultures were set up at 2 x 106 cells/ml in RPMI 1640 with 10 mM-HEPES pH 7.2 supplemented as above but with 10 % FCS (RPMI/10% FCS) and with 5U/ml recombinant human interleukin-2 (rHu IL-2; NIBSC, Potters Bar, U.K.). Efferent lymph cells were also cultured in this medium supplemented with 200 lag/ml gentamicin. Lymphocytes (2 x l0 s) were added to 105 autologous skin ceils which had been infected with 0.5 TCIDs0/cell MVV strain EV1 in DMEM/2% FCS for 90 to 120min at 37°C in 24-well plates. Lymphocyte cultures were fed with 0'5 ml IL-2-supplemented medium after 3 to 4 days, incubated at 37 °C in 5 % CO s and cultured for a further 3 to 4 days. The cells were harvested, resuspended at 1 x l0 s live cells/ml in RPMI/10% FCS with IL-2 and replated on infected autologous skin cells and cultured with feeding as above for a total of 14 days. The cells were then harvested, centrifuged over Lymphoprep (800g for 10 min) and the cells collected from the interface were washed twice in RPMI/2 % FCS before resuspension in RPMI/10 % FCS at the required concentration for CTL assays. Live cell concentrations were determined by trypan blue dye exclusion.
Uncultured lymphocyte effectors. Efferent lymph cells and PBMC
were prepared as above, and suspended in RPMI/10% FCS at the required concentration for CTL assays.
CTL assay. Lymphocyte effectors were adjusted to the required concentration for effector:target ratios of 3:1 to 100:1 before incubation with target cells for 6 to 18 h at 37°C in a 5% CO s atmosphere. The targets used were 104 autologous or heterologous skin cells either mock-infected or infected with 0.2 to 2 TCIDs0 MVV per cell (depending on the virus stock) for 48 to 72 h or 10 p.f.u. VgD52 per cell for 8 h at the end of the assay. Cells were labelled with 2.5 to 3 pCi ~lCr (sodium chromate, 350 to 600 mCi/mg Cr, Amersham) per 104 cells overnight at 37 °C in 5 % CO s before washing four times with RPMI/2 % FCS and then incubated with effectors in RPMI/10 % FCS in a total assay volume of 200 ~tl. Supernatant (100 ~tl) was counted in a LKB Wallac 1274 RIAGAMMA counter and the results were expressed as the percentage specific 51Cr release (mean experimental 51Cr release-mean spontaneous ~Cr release)/(mean maximum 5~Cr release-mean spontaneous 51Cr release)x 100_+(standard deviation of experimental 51Cr release)/(mean maximum 51Cr release-mean spontaneous 5~Cr release) x 100. The percentage MVV-specific cytotoxicity is (percentage specific 51Cr release from infected targets) -(percentage specific 51Cr release from mock-infected targets)___ sum of their standard deviations. All values were obtained from triplicate or quadruplicate samples and spontaneous 51Cr release was always less than 30 % of the maximum release.
Depletion of lymphocyte populations (i) Magnetic cell sorting (MACS). Effector lymphocytes in PBS/1%
FCS were sorted as previously described (Reyburn et al., 1992) . Briefly, they were treated with biotinylated MAbs SBU-T4 or SBU-T8 (Maddox et al., 1985) (23 ng/107 cells for 30 min at 0 °C) followed by streptavidin-fluorescein isothiocyanate (FITC) (Boehringer Mannheim) in PBS/5 mM-EDTA for 15 min at 0 °C. After washing, the cells were incubated with superparamagnetic biotinylated microbeads (Becton Dickinson) and applied to a magnetized MACS iron mesh column (number of beads/cell and size of column as recommended by Becton Dickinson Immunocytometry Systems) preincubated in PBS/1% FCS/5 mM-EDTA. Unlabelled cells were washed through the column (depleted population) and after extensive washing the labelled cells were flushed from the demagnetized column (enriched population).
(it) Complement-mediated depletion. All reactions and washes were carried out in RPMI/2 % FCS. Effector lymphocytes were incubated with MAbs SBU-T4, SBU-T8 or an irrelevant IgG2a mouse myeloma protein (UPC10; Sigma) (0-5 ~tg/107 cells) for 40 rain at 0 °C and then washed twice. They were then incubated with rabbit complement (3-week-old rabbit serum collected on ice and stored at -70 °C, 0"5 ml of a 1 : 5 dilution) for 30 min at 37 °C, washed once and reincubated with complement as above before being washed twice, resuspended in RPMI/10% FCS and used in CTL assays.
Fluorescence activated cell sorter (FA CS) analysis of cellpopulations.
Reactions and washes were carried out in RPMI/2 % FCS. Cells were labelled with MAbs ST-4 (Hopkins, 1991) , ST-8 (Ezaki et al., 1987 ) or DU2-104 (MacKay et al., 1992 as above, washed three times and then developed with FITC-conjugated anti-mouse IgG 1 or IgM respectively (The Binding Site). Normal mouse serum (1:500) was used as the negative control primary antibody. After washing twice, cells were resuspended in 20 ~tg/ml propidium iodide and analysed in a Becton Dickinson FACScan. FACScan Research Software Version 2.1 was used to exclude dead cells by gating out those with high propidium iodide intake and low FSC values and then 7000 cells per sample were collected and analysed on LYSYS Version 1.62.
Results
We looked for CTL specific for MVV in the circulating lymphocyte pool of sheep by taking efferent lymph cells and peripheral blood cells and using them in 51Cr release assays against MVV or mock-infected autologous and heterologous skin cells. ( Fig. l b and d) . There was no specific lysis of heterologous infected targets showing that the response was apparently major histocompatability complex (MHC) restricted. Although longer incubation periods were usually used (16 to 18 h, Fig. lb ) lysis could be observed after only 8 h (Fig. 1 d) . Cultured lymphocytes from sheep 1540A were separated by MACS into CD4 + and CD8 + cell-enriched populations (93 % CD4 + and 78 % CD8 + cells, respectively) and CD4 + and CD8 + celldepleted populations (9 % CD4 +, 65 % CD8 + and 65 % CD4 ÷, 9 % CD8 + cells, respectively) and used as effectors in 51Cr release assays ( 
Peripheral blood
Peripheral blood lymphocytes from persistently infected (n = 5) and also uninfected (n--10) sheep were also tested for the presence of precursor CTL after culture in the presence of IL-2 and live MVV antigen. Only persistently infected sheep (all of five) showed MHCrestricted killing of MVV-infected targets (Fig. 2 a and c) . No activity was detected in uninfected sheep (Fig. 2b) . 9.0 ± 0.5 4.9 ± 1"0 autologous 6.7 _ 0.6 4.0 _+ 0.5 6.3 + 1"9 MVV-infected: heterologous 13"9+3'3 14.2+1.0 3.84-1"3 autologous 47-7+3-4 43.5+ 1.0 2.4+0"7 Uninfected: heterologous 2-3 ± 0.9 9.7 ± 1.5 0-9 ± 3-3 autologous 4.8 ± 2.7 6"2 + 1.3 0"3 ± 2.2 MVV-infected: heterologous 4.6-t-1.0 12.8±0-6 3.4+2.7 autologous 21'1 _ 1.8 35.5 ±4.0 7-1 ± 1.9 * Effector:target ratio of 6:1 except mock-depleted 12:1. t Percentage specific 5aCr release. :~ Effector:target ratio of 25: 1.
Using complement depletion of antibody-labelled cells, the effector cell population was again shown to be CD8 + lymphocytes (Table 2 ) in all the sheep tested. The CTL activity demonstrated was MW-specific as recombinant vaccinia virus-infected target cells were not lysed (Fig. 2d) . However there was variability in the recognition of two strains of MVV in these assays. One sheep (Fig. 2c) showed equivalent levels of lysis with both strain EV1 (used to infect both sheep shown here) and strain 1514 but a second sheep showed no recognition of strain 1514 at the same infectious dose of virus on the target cells (data not shown) or at a higher infectious dose (Fig. 2a) which causes distinct c.p.e, on the target cells. When there was recognition of strain 1514 it was MHC-restricted in the same way as was the case for strain EV1. Some sheep showed intermediate levels of recognition of 1514 (data not shown).
When uncultured PBMC were assayed for CTL activity, only one out of seven persistently infected (> 18 months p.i.) sheep showed MHC-restricted lysis of MVV-infected targets (Fig. 3 a) . After MACS the effector cell population was again shown to be CD8 + (Fig. 3 b) not CD4 + lymphocytes (Fig. 3c ). This population was IL-2 receptor-negative (CD25-) by FACS double staining of the CD8 + cell-enriched population (data not shown).
Time of appearance of precursor CTL in peripheral blood
Four sheep were infected with MVV strain EV1 (10 s TCIDs0 ) and the appearance of precursor CTL to MVV was monitored in the peripheral blood by culture and assay. All sheep became positive for precursor CTL to MW by day 100 p.i. (Table 3 ). The first sheep to show MHC-restricted MW-specific lysis was 1091P (positive by day 24 p.i.) which had unusually high levels of CD8 ÷ lymphocytes (40 %) in its peripheral blood both pre-and post-infection; the normal range is between 10 and 20 % (MacKay et al., 1988; Evans, 1993) . This sheep was clinically normal so we have no explanation for this phenomenon. All four of the above sheep were antibodypositive to MVV antigen by day 45 p.i. (Table 3) . After infection the MHC-restricted, MVV-specific lysis of target cells was shown to be due to CD8 + lymphocytes in all four sheep (data not shown). A further group of three sheep infected as above were all precursor CTL-positive by day 87 p.i. (data not shown). It is therefore expected that most MVV-infected sheep should become precursor CTL-positive in the blood within the first 3 months p.i. Once sheep had become positive for CTL, assays were consistently positive when conducted later. Some preinfection assays showed MVV-specific lysis of heterologous as well as autologous infected target cells and this may be due to the presence of natural killer cell populations in these cultures; however no phenotypic characterization of these cells was undertaken.
Discussion
The data presented here show that MVV-specific precursor CTL are present in the circulating lymphocyte pool of infected sheep and that the effector population consists of CD8 + lymphocytes. Little work has been published on the CTL response to MVV. One report has stated that superinfected macrophages from MVVinfected sheep may act as targets for in vitro stimulated peripheral blood lymphocytes but the phenotype of the effector cell population was not determined (KennedyStoskopf, 1989) . The lent±virus most closely related to MVV is caprine arthritis-encephalitis virus (CAEV) which causes arthritis and encephalitis in persistently infected goats. Lichtensteiger et al. (1993) sistently infected goats. They used a culture system similar to that reported here (infected dermal fibroblasts used to present live viral antigen) and showed that the effector cells were CD8 +. Although lesions arise in many organs in MVVinfected sheep, the underlying pathology is common to all sites. This is a lymphocytic inflammatory infiltrate which may organize into follicular-like structures but which will eventually destroy normal tissue architecture (reviewed in Blacklaws et aL, 1994) . Often there is a major CD8 + lymphocyte population in the affected tissue [lungs: Watt et al., 1992; joints: Harkiss et al., 1991; Anderson et al., 1994 ; cerebrospinal fluid (CSF): Torsteinsdottir et al., 1992] but the contribution of these lymphocytes to pathology is unclear. From the evidence presented here one of the major functions of the CD8 + lymphocytes may be to clear virus-infected macrophages from the sites of infection. This may be why little MVV antigen is seen in lesions.
In HIV and SIV infections there is good evidence for the role of CTL in the immune surveillance of lentivirusinfected cells. When the CTL precursor frequency starts to decrease in late stage infection there is a concomitant rise in the infectious virus titre and this is closely followed by clinical immunodeficiency and death (Carmichael et al., 1993; Nixon, 1992) . Chronic MVV infection can therefore be considered to be analogous to the asymptomatic stage of disease in immunodeficiency virus-infected animals. CTL precursors have been detected in the blood of HIV-infected humans, SIVinfected primates and FIV-infected cats (Nixon, 1992; Letvin, 1991; Song et al., 1992) and in the CSF, lymph nodes, lungs and skin of HIV-and/or SIV-infected patients and primates (Plata et al., 1987; Jassoy et al., 1992; Reimann et al., 1991) . Lymph nodes especially are thought to be major reservoirs of latently infected cells (Embretson et al., 1993; Pantaleo et al., 1993) and the presence of CTL precursors in lymph nodes suggests a role for these in limiting viral replication. We have shown that CTL precursors are present in efferent lymphatics draining infected lymph nodes and have preliminary evidence for the presence of CTL in the lymph nodes of MVVinfected sheep (data not shown).
CTL were first detected in the blood of sheep between 3 weeks and 3 months after subcutaneous infection with MVV. This is similar to the appearance of CTL in FIV infection after intraperitoneal challenge (Song et al., 1992) . However following intravenous SIV infection, peripheral blood CTL were observed within 4 to 6 days (Yasutomi et al., 1993) . Following acute MVV infection of a peripheral lymph node via the skin we have evidence that CTL precursors can be detected as early as 6 days p.i. in draining efferent lymph (data not shown). The lag period between detection in blood or at local sites of infection may be due to a dilution effect within the whole animal or homing of specific lymphocytes to sites of viral replication.
There is a high frequency of CTL in HIV-infected patients and SIV-infected rhesus monkeys. This is shown by the fact that in 15 to 85 % of patients (Nixon, 1992) and four out of four infected macaques (Vowels et al., 1989) killing is seen with PBMC without secondary in vitro stimulation. Although precursor frequencies have not been measured here, in only one of seven (14%) persistently infected sheep were fresh peripheral blood CD8 + cells active in these assays. Although the CD8 + cells were apparently IL-2 receptor-negative (CD25-), in these assays very high effector: target ratios were necessary, suggesting a very low frequency of effector cells below the sensitivity of FACS analysis. An expanded population of CD8 + lymphocytes expressing MHC class II DR, CD38 and CD25 have been documented in HIVinfected individuals (Kestens et al., 1992; Watret et al., 1993) and indeed 16 to 21% of CD8 + cells were CD25 + after in vitro culture here (data not shown).
The effector cell population here is CD8 + and it is probably MHC class I-restricted as the skin cells used for targets are MHC class II-negative by FACS staining (data not shown). This is supported by the lack of any evidence for CD4 + effector lymphocytes in subset depletion experiments. However CD4 + CTL have been documented in infection with both HIV and SIV (Nixon, 1992) .
All the structural proteins of HIV-1 and SIV (gag, pol and env) contain epitopes recognized by virus-specific CTL and similarly most of the regulatory proteins express epitopes recognized by CD8 + lymphocytes (Nixon & McMichael, 1991) . Indeed the immunodominant epitope in certain MHC backgrounds may be within the nef protein (Venet et al., 1992; Chenciner et al., 1989) . Using selection of CTL on EVI strain MVV, there was variation in the recognition of two strains of MVV within different animals. This is because of differences in the expressed protein sequences of these two strains of MVV, for example the rev amino acid sequence is 35 % different between EV1 and 1514 (Sargan et al., 1991) and also in the presentation of particular epitopes on MHC class I alleles. The MHC background of the animals used has not been investigated by protein biochemistry. There is also marked variation in the recognition of different CAEV isolates by CTL (Lichtensteiger et al., 1993) .
MVV induces an apparently normal antiviral immune response but the virus persists in chronically infected animals. Lymphoid tissue is now thought to be the site of viral persistence in HIV infection (Pantaleo et al., 1993; Embretson et al., 1993) . In MVV infection, virus-infected macrophages found in the bone marrow may be a continuous source of infected cells (Gendelman et al., 1985) . It has also been well documented for MVV that virus replication in infected myeloid cells is heavily dependent on the state of differentiation of the macrophage such that a restricted replication state has been suggested in monocytes and other cells (Gendelman et al., 1986; Haase, 1986) . We are at present studying whether MVV-infected macrophages are recognized by CTL generated by these methods and the specificity of the immune response in relation to the state of viral replication after acute infection. This will help to clarify the importance of CTL in controlling lentiviral infections.
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